Overview
Tim Verweij practices in Leiden, Netherlands. Mr. Verweij is rated as an Advanced expert by MediFind in the treatment of Alpha Thalassemia. His top areas of expertise are Hemolytic Disease of the Newborn, Fetal Edema, Hydrops Fetalis, and Alpha Thalassemia.
His clinical research consists of co-authoring 26 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Alpha Thalassemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Hemolytic Disease of the NewbornMr. Verweij isDistinguished. Learn about Hemolytic Disease of the Newborn.
- Advanced
- Alpha ThalassemiaMr. Verweij isAdvanced. Learn about Alpha Thalassemia.
- Fetal and Neonatal Alloimmune Thrombocytopenia
- Fetal EdemaMr. Verweij isAdvanced. Learn about Fetal Edema.
- Hydrops FetalisMr. Verweij isAdvanced. Learn about Hydrops Fetalis.
- Experienced
- AnemiaMr. Verweij isExperienced. Learn about Anemia.
- CraniopharyngiomaMr. Verweij isExperienced. Learn about Craniopharyngioma.
- Fetal Parvovirus SyndromeMr. Verweij isExperienced. Learn about Fetal Parvovirus Syndrome.
- Fifth DiseaseMr. Verweij isExperienced. Learn about Fifth Disease.
- HemoglobinopathyMr. Verweij isExperienced. Learn about Hemoglobinopathy.
- Intrauterine Growth RestrictionMr. Verweij isExperienced. Learn about Intrauterine Growth Restriction.